Merck tried to cut cardiovascular risk in Cox-2 drugs before Vioxx hit market

NEW YORK (AP) - Merck & Co. sought patent protection for a way to reduce cardiovascular problems in Cox-2 inhibitors, the class of drugs that includes Vioxx, as early as 1998 - a year before the popular pain killer was introduced, newly disclosed documents show....More